Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) describes a group of chronic inflammatory rheumatic diseases primarily involving the axial skeleton. IL-17 is involved in the pathogenesis of numerous inflammatory diseases, including inflammatory arthritis. Until a few years ago, the only biological agents licensed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzeni, Fabiola, Carriero, Antonio, Boccassini, Laura, D’Angelo, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104974/
https://www.ncbi.nlm.nih.gov/pubmed/33977094
http://dx.doi.org/10.2147/ITT.S259126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104974/
https://www.ncbi.nlm.nih.gov/pubmed/33977094
http://dx.doi.org/10.2147/ITT.S259126

Ejemplares similares